These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

573 related items for PubMed ID: 19826038

  • 21. Vitamin E analogs trigger apoptosis in HER2/erbB2-overexpressing breast cancer cells by signaling via the mitochondrial pathway.
    Wang XF, Witting PK, Salvatore BA, Neuzil J.
    Biochem Biophys Res Commun; 2005 Jan 14; 326(2):282-9. PubMed ID: 15582575
    [Abstract] [Full Text] [Related]

  • 22. HDAC inhibitor vorinostat enhances the antitumor effect of gefitinib in squamous cell carcinoma of head and neck by modulating ErbB receptor expression and reverting EMT.
    Bruzzese F, Leone A, Rocco M, Carbone C, Piro G, Caraglia M, Di Gennaro E, Budillon A.
    J Cell Physiol; 2011 Sep 14; 226(9):2378-90. PubMed ID: 21660961
    [Abstract] [Full Text] [Related]

  • 23. Identification of patients with transitional cell carcinoma of the bladder overexpressing ErbB2, ErbB3, or specific ErbB4 isoforms: real-time reverse transcription-PCR analysis in estimation of ErbB receptor status from cancer patients.
    Junttila TT, Laato M, Vahlberg T, Söderström KO, Visakorpi T, Isola J, Elenius K.
    Clin Cancer Res; 2003 Nov 01; 9(14):5346-57. PubMed ID: 14614020
    [Abstract] [Full Text] [Related]

  • 24. ERBB2-mediated transcriptional up-regulation of the alpha5beta1 integrin fibronectin receptor promotes tumor cell survival under adverse conditions.
    Spangenberg C, Lausch EU, Trost TM, Prawitt D, May A, Keppler R, Fees SA, Reutzel D, Bell C, Schmitt S, Schiffer IB, Weber A, Brenner W, Hermes M, Sahin U, Türeci O, Koelbl H, Hengstler JG, Zabel BU.
    Cancer Res; 2006 Apr 01; 66(7):3715-25. PubMed ID: 16585198
    [Abstract] [Full Text] [Related]

  • 25. ErbB2-enhanced invasiveness of H-Ras MCF10A breast cells requires MMP-13 and uPA upregulation via p38 MAPK signaling.
    Yong HY, Kim IY, Kim JS, Moon A.
    Int J Oncol; 2010 Feb 01; 36(2):501-7. PubMed ID: 20043086
    [Abstract] [Full Text] [Related]

  • 26. Simultaneous inhibition of DNA methyltransferase and histone deacetylase induces p53-independent apoptosis via down-regulation of Mcl-1 in acute myelogenous leukemia cells.
    Nishioka C, Ikezoe T, Yang J, Udaka K, Yokoyama A.
    Leuk Res; 2011 Jul 01; 35(7):932-9. PubMed ID: 21550660
    [Abstract] [Full Text] [Related]

  • 27. Acquired resistance to small molecule ErbB2 tyrosine kinase inhibitors.
    Chen FL, Xia W, Spector NL.
    Clin Cancer Res; 2008 Nov 01; 14(21):6730-4. PubMed ID: 18980964
    [Abstract] [Full Text] [Related]

  • 28. ErbB3-dependent motility and intravasation in breast cancer metastasis.
    Xue C, Liang F, Mahmood R, Vuolo M, Wyckoff J, Qian H, Tsai KL, Kim M, Locker J, Zhang ZY, Segall JE.
    Cancer Res; 2006 Feb 01; 66(3):1418-26. PubMed ID: 16452197
    [Abstract] [Full Text] [Related]

  • 29. c-Src modulates ErbB2 and ErbB3 heterocomplex formation and function.
    Ishizawar RC, Miyake T, Parsons SJ.
    Oncogene; 2007 May 24; 26(24):3503-10. PubMed ID: 17173075
    [Abstract] [Full Text] [Related]

  • 30. Peptide aptamers with binding specificity for the intracellular domain of the ErbB2 receptor interfere with AKT signaling and sensitize breast cancer cells to Taxol.
    Kunz C, Borghouts C, Buerger C, Groner B.
    Mol Cancer Res; 2006 Dec 24; 4(12):983-98. PubMed ID: 17189388
    [Abstract] [Full Text] [Related]

  • 31. Overexpression of both TFPIα and TFPIβ induces apoptosis and expression of genes involved in the death receptor pathway in breast cancer cells.
    Stavik B, Skretting G, Sletten M, Sandset PM, Iversen N.
    Mol Carcinog; 2010 Nov 24; 49(11):951-63. PubMed ID: 20886581
    [Abstract] [Full Text] [Related]

  • 32. MS-275, a novel histone deacetylase inhibitor with selectivity against HDAC1, induces degradation of FLT3 via inhibition of chaperone function of heat shock protein 90 in AML cells.
    Nishioka C, Ikezoe T, Yang J, Takeuchi S, Koeffler HP, Yokoyama A.
    Leuk Res; 2008 Sep 24; 32(9):1382-92. PubMed ID: 18394702
    [Abstract] [Full Text] [Related]

  • 33. Downregulation of erbB3 abrogates erbB2-mediated tamoxifen resistance in breast cancer cells.
    Liu B, Ordonez-Ercan D, Fan Z, Edgerton SM, Yang X, Thor AD.
    Int J Cancer; 2007 May 01; 120(9):1874-82. PubMed ID: 17266042
    [Abstract] [Full Text] [Related]

  • 34. RNA interference-mediated depletion of phosphoinositide 3-kinase activates forkhead box class O transcription factors and induces cell cycle arrest and apoptosis in breast carcinoma cells.
    Reagan-Shaw S, Ahmad N.
    Cancer Res; 2006 Jan 15; 66(2):1062-9. PubMed ID: 16424042
    [Abstract] [Full Text] [Related]

  • 35. Novel anti-ErbB3 monoclonal antibodies show therapeutic efficacy in xenografted and spontaneous mouse tumors.
    Aurisicchio L, Marra E, Luberto L, Carlomosti F, De Vitis C, Noto A, Gunes Z, Roscilli G, Mesiti G, Mancini R, Alimandi M, Ciliberto G.
    J Cell Physiol; 2012 Oct 15; 227(10):3381-8. PubMed ID: 22213458
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Vector-mediated HER-2 RNA interference against HER-2-positive breast cancer].
    Hu XQ, Qin L, Su FX, Yao HR, Chen JS, Gong C, Guo JJ, Yu FY, Jia HX.
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 May 15; 26(5):570-2. PubMed ID: 16762851
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Incomplete surgical resection of ductal carcinomas in situ results in activation of ERBB2 in residual breast cancer cells.
    Singer CF, Hudelist G, Fuchs EM, Köstler W, Fink-Retter A, Gschwantler-Kaulich D, Gnant M, Lamm W, Rudas M, Czerwenka K, Kubista E.
    Endocr Relat Cancer; 2009 Mar 15; 16(1):73-83. PubMed ID: 18948375
    [Abstract] [Full Text] [Related]

  • 40. Inhibition of histone deacetylase enhances the anti-proliferative action of antiestrogens on breast cancer cells and blocks tamoxifen-induced proliferation of uterine cells.
    Hodges-Gallagher L, Valentine CD, Bader SE, Kushner PJ.
    Breast Cancer Res Treat; 2007 Nov 15; 105(3):297-309. PubMed ID: 17186358
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 29.